113 related articles for article (PubMed ID: 2810131)
21. Different immune functions of peripheral blood, regional lymph node, and tumor infiltrating lymphocytes in lung cancer patients.
Nakamura H; Ishiguro K; Mori T
Cancer; 1988 Dec; 62(12):2489-97. PubMed ID: 3142676
[TBL] [Abstract][Full Text] [Related]
22. A cell-free Salmonella typhimurium extract modulates interleukin-2 (IL-2) receptor expression but not IL-2-stimulated responses of murine splenic lymphocytes.
Matsui K; Arai T
FEMS Immunol Med Microbiol; 1994 Aug; 9(2):125-33. PubMed ID: 7804163
[TBL] [Abstract][Full Text] [Related]
23. T-cells infiltrating renal cell carcinoma display a poor proliferative response even though they can produce interleukin 2 and express interleukin 2 receptors.
Alexander JP; Kudoh S; Melsop KA; Hamilton TA; Edinger MG; Tubbs RR; Sica D; Tuason L; Klein E; Bukowski RM
Cancer Res; 1993 Mar; 53(6):1380-7. PubMed ID: 8443817
[TBL] [Abstract][Full Text] [Related]
24. Tumor-reactive T-cells accumulate in lung cancer tissues but fail to respond due to tumor cell-derived factor.
Yoshino I; Yano T; Murata M; Ishida T; Sugimachi K; Kimura G; Nomoto K
Cancer Res; 1992 Feb; 52(4):775-81. PubMed ID: 1737336
[TBL] [Abstract][Full Text] [Related]
25. Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor.
Itoh K; Platsoucas CD; Balch CM
J Exp Med; 1988 Oct; 168(4):1419-41. PubMed ID: 3262710
[TBL] [Abstract][Full Text] [Related]
26. [Treatment with autologous tumor-infiltrating lymphocytes and recombinant interleukin-2 in patients with lung carcinoma].
Li D; Zhang X; Song Y
Zhonghua Zhong Liu Za Zhi; 1995 Mar; 17(2):152-5. PubMed ID: 7656811
[TBL] [Abstract][Full Text] [Related]
27. Cytokinetic basis for the impaired activation of lymphocytes from patients with primary intracranial tumors.
Elliott LH; Brooks WH; Roszman TL
J Immunol; 1984 Mar; 132(3):1208-15. PubMed ID: 6319491
[TBL] [Abstract][Full Text] [Related]
28. The tumor promoter teleocidin induces IL 2 receptor expression and IL 2-independent proliferation of human peripheral blood T cells.
Isakov N; Bleackley RC; Shaw J; Altman A
J Immunol; 1985 Oct; 135(4):2343-50. PubMed ID: 3928744
[TBL] [Abstract][Full Text] [Related]
29. Cell-mediated immune status in patients with squamous cell carcinoma of the oral cavity.
Saranath D; Mukhopadhyaya R; Rao RS; Fakih AR; Naik SL; Gangal SG
Cancer; 1985 Sep; 56(5):1062-70. PubMed ID: 3874683
[TBL] [Abstract][Full Text] [Related]
30. Promotion of human T lymphocyte proliferation by IL-4.
Mitchell LC; Davis LS; Lipsky PE
J Immunol; 1989 Mar; 142(5):1548-57. PubMed ID: 2783946
[TBL] [Abstract][Full Text] [Related]
31. Clonal and frequency analyses of tumor-infiltrating T lymphocytes from human solid tumors.
Miescher S; Whiteside TL; Moretta L; von Fliedner V
J Immunol; 1987 Jun; 138(11):4004-11. PubMed ID: 3108380
[TBL] [Abstract][Full Text] [Related]
32. In vitro analysis of the proliferative potential of T cells from patients with brain tumor: glioma-associated immunosuppression unrelated to intrinsic cellular defect.
McVicar DW; Davis DF; Merchant RE
J Neurosurg; 1992 Feb; 76(2):251-60. PubMed ID: 1730954
[TBL] [Abstract][Full Text] [Related]
33. Effect of phorbol myristate acetate on T cell colony formation, interleukin-2 (IL-2) receptor expression and IL-2 production by cells from patients at all stages of HIV infection.
Allouche M; Lunardi-Iskandar Y; Varela-Millot C; Itzhaki M; Cornuet P; Meyer P; Jasmin C; Georgoulias V
Clin Exp Immunol; 1990 Aug; 81(2):200-6. PubMed ID: 1696861
[TBL] [Abstract][Full Text] [Related]
34. Altered gene transcription after burn injury results in depressed T-lymphocyte activation.
Horgan AF; Mendez MV; O'Riordain DS; Holzheimer RG; Mannick JA; Rodrick ML
Ann Surg; 1994 Sep; 220(3):342-51; discussion 351-2. PubMed ID: 8092900
[TBL] [Abstract][Full Text] [Related]
35. Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer.
Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Stathopoulos GP; Papamichail M
Cancer; 1994 Aug; 74(4):1275-82. PubMed ID: 7914469
[TBL] [Abstract][Full Text] [Related]
36. Reduction of interleukin-2-receptor expression on retroplacental blood lymphocytes in human pregnancy.
Yoshida M; Kanzaki H; Kariya M; Emi N; Imai K; Okamoto N; Uchida A; Kasakura S; Mori T
Am J Reprod Immunol; 1990; 22(1-2):1-3. PubMed ID: 2346591
[TBL] [Abstract][Full Text] [Related]
37. Characterization of the requirements for human T cell mitogenesis by using suboptimal concentrations of phytohemagglutinin.
Mills GB; Lee JW; Cheung RK; Gelfand EW
J Immunol; 1985 Nov; 135(5):3087-93. PubMed ID: 2995486
[TBL] [Abstract][Full Text] [Related]
38. The effects of blockade of interleukin 2 receptors and interleukin 4 receptors on cytokine production.
Lai KN; Leung JC; Li PK; Larche M; Ritter MA
APMIS; 1991 May; 99(5):434-42. PubMed ID: 1904250
[TBL] [Abstract][Full Text] [Related]
39. Functional properties of the 50 kd protein associated with the E-receptor on human T lymphocytes: suppression of IL 2 production by anti-p50 monoclonal antibodies.
Tadmori W; Reed JC; Nowell PC; Kamoun M
J Immunol; 1985 Mar; 134(3):1709-16. PubMed ID: 2981919
[TBL] [Abstract][Full Text] [Related]
40. Retinoic acid upregulates interleukin-2 receptors on activated human thymocytes.
Sidell N; Ramsdell F
Cell Immunol; 1988 Sep; 115(2):299-309. PubMed ID: 3136932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
